People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Torque Therapeutics, Inc. | — | Biotechnology | Series C | $84.3M | $1.6B | 2019 |
| Quanterix Corp | — | Other Technology | Series C | $71.8M | $194.1M | 2019 |
Douglas G. Cole at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas G. Cole on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Connolly | 1 | 14 |
| Paul Meister | 1 | 12 |
| Keith Crandell | 1 | 11 |
| John M. Connolly | 1 | 6 |
| David Walt | 1 | 6 |
| David R. Walt | 1 | 5 |
| Douglas Cole | 1 | 5 |
| David Okrongly | 1 | 4 |
| Marijn Dekkers | 1 | 4 |
| PAUL M MEISTER | 1 | 4 |
| Martin Madaus | 1 | 3 |
| Bart Henderson | 1 | 3 |
| Keith L. Crandell | 1 | 3 |
| Paul Chapman | 1 | 3 |
| Joseph Driscoll | 1 | 2 |
| Kevin Hrusovsky | 1 | 2 |
| ULRIK B. NIELSEN | 1 | 2 |
| JOHN G. COX | 1 | 2 |
| E. Kevin Hrusovsky | 1 | 2 |
| Amol Kevin Chaubal | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.